Trial intelligence / Profile preview

Propofol + remifentanil dosing for pediatric tracheal intubation without muscle relaxant

ChiCTR2000034220Phase 4Not yet recruiting

Sponsor
Zhongshan Boai Hospital
Start
Jun 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol and remifentanil in inguinal hernia (3 arms), sponsored by Zhongshan Boai Hospital. Primary endpoint: Intubation response. Planned start Jun 2020; status: not yet recruiting.

02

Drugs

propofolremifentanil
03

Conditions

inguinal hernia

Beyond the preview

Go deeper on ChiCTR2000034220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call